Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Central venous catheter-associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice.

Authors:
Ceder H van den Bosch Judith Spijkerman Marc H W A Wijnen Idske C L Kremer Hovinga Friederike A G Meyer-Wentrup Alida F W van der Steeg Marianne D van de Wetering Marta Fiocco Indra E Morsing Auke Beishuizen

Support Care Cancer 2022 Jul 1. Epub 2022 Jul 1.

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Purpose: The purpose of this study was to determine the most optimal central venous catheter (CVC) for pediatric patients with Hodgkin lymphoma (HL) in terms of complications.

Methods: A retrospective study including patients diagnosed with HL from 2015 to 2021 at the Princess Máxima Center was performed. Patients were followed from CVC insertion until removal or 06-2021, whichever came first. The primary outcome was the CVC-related complication incidence rate (IR) per 1000 CVC-days. Furthermore, the incidence rate ratio (IRR) was calculated by comparing complication IRs between peripherally inserted central catheters (PICC) and totally implantable venous access ports (TIVAP). Additionally, risk factors for central venous thrombosis (CVT) were identified.

Results: A total of 98 patients were included. The most frequently observed complications were local irritation/infections (18%; IR 0.93), malfunctions (15%; IR 0.88), and CVC-related CVTs (10%; IR 0.52). Single lumen PICCs were associated with a higher risk of complications (49% vs. 26%; IRR 5.12, CI95% 2.76-9.50), severe complications (19% vs. 7%; IRR 11.96, CI95% 2.68-53.42), and early removal (18% vs. 7%; IRR 9.96, CI95% 2.18-45.47). A single lumen PICC was identified as a risk factor for CVC-related CVT when compared to TIVAPs (12% vs. 7%, IRR 6.98, CI95% 1.45-33.57).

Conclusion: The insertion of a TIVAP rather than a PICC should be recommended for pediatric patients with HL, especially in the presence of CVT-related risk factors. Future trials should evaluate the efficacy and safety of direct oral anticoagulants for the primary prevention of CVT in pediatric patients with a PICC and other CVT-related risk factors.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-022-07256-3DOI Listing
July 2022

Publication Analysis

Top Keywords

pediatric patients
16
central venous
12
risk factors
12
patients diagnosed
8
single lumen
8
hodgkin lymphoma
8
incidence rate
8
cvt-related risk
8
patients
7
irr
5
risk
5
cvc-related cvts
4
cvts 10%
4
10% 052
4
088 cvc-related
4
052 single
4
15% 088
4
malfunctions 15%
4
central
4
lumen piccs
4

Keyword Occurance

Similar Publications

Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial.

Authors:
Hermine I Brunner Ivan Foeldvari Ekaterina Alexeeva Nuray Aktay Ayaz Inmaculada Calvo Penades Ozgur Kasapcopur Vyacheslav G Chasnyk Markus Hufnagel Zbigniew Żuber Grant Schulert Seza Ozen Adelina Rakhimyanova Athimalaipet Ramanan Christiaan Scott Betul Sozeri Elena Zholobova Ruvie Martin Xuan Zhu Sarah Whelan Luminita Pricop Alberto Martini Daniel Lovell Nicolino Ruperto

Ann Rheum Dis 2022 Aug 12. Epub 2022 Aug 12.

IRCCS Istituto Giannina Gaslini, UOSID Centro Trial, Genova, Italy.

Background: Treatment options in patients with enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA) are currently limited. This trial aimed to demonstrate the efficacy and safety of secukinumab in patients with active ERA and JPsA with inadequate response to conventional therapy.

Methods: In this randomised, double-blind, placebo-controlled, treatment-withdrawal, phase 3 trial, biologic-naïve patients (aged 2 to <18 years) with active disease were treated with open-label subcutaneous secukinumab (75/150 mg in patients <50/≥50 kg) in treatment period (TP) 1 up to week 12, and juvenile idiopathic arthritis (JIA) American College of Rheumatology 30 responders at week 12 were randomised 1:1 to secukinumab or placebo up to 100 weeks. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

A population-based analysis of the presentation and outcomes of pediatric patients with osteosarcoma in Canada: a report from CYP-C.

Authors:
Michael J Horkoff Joseph K Kendal Christopher Blackmore Tony H Truong Gregory M T Guilcher Mary E Brindle

Can J Surg 2022 Jul-Aug;65(4):E527-E533. Epub 2022 Aug 12.

Department of Surgery, Sections of General Surgery (Horkoff) and Orthopaedic Surgery (Kendal), University of Calgary, Calgary, Alta.; Department of Surgery, Division of Pediatric General Surgery (Blackmore), Dalhousie University, Halifax, NS; Arnie Charbonneau Cancer Research Institute (Truong, Guilcher), Department of Oncology, and Alberta Children's Hospital Research Institute (Truong, Guilcher, Brindle), Department of Pediatrics, Cumming School of Medicine (Truong, Guilcher), and Department of Surgery (Brindle), Section of Pediatric Surgery, University of Calgary, Calgary, Alta.

Background: Frequently occurring in adolescents, osteosarcoma is the most common primary malignant bone disease, with a reported 15% of patients who present with metastasis. With advances in imaging and improvements in surgical care, an updated analysis is warranted on the outcomes of pediatric patients with osteosarcoma.

Methods: We completed a retrospective review of pediatric patients who presented with osteosarcoma between 2001 and 2017, using The Cancer in Young People in Canada (CYP-C) national database. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Modes of failure of hip hemiarthroplasty for femoral neck fracture.

Authors:
Taranjit Tung Trevor C Gascoyne Elly Trepman Carole H Stipelman Sarah Tran Eric R Bohm Colin D Burnell David R Hedden Thomas R Turgeon

Can J Surg 2022 Jul-Aug;65(4):E519-E526. Epub 2022 Aug 12.

From the Department of Surgery, Section of Orthopaedic Surgery, Max Rady College of Medicine, University of Manitoba, Winnipeg, Man. (Tung, Trepman, Bohm, Burnell, Hedden, Turgeon); the Orthopaedic Innovation Centre, Winnipeg, Man. (Gascoyne, Tran); the Departments of Pediatrics and Medical Informatics, University of Utah School of Medicine, Salt Lake City, UT (Stipelman); the Concordia Joint Replacement Group, Concordia Hip & Knee Institute, Winnipeg, Man. (Tung, Trepman, Bohm, Burnell, Hedden, Turgeon); the Department of Medical Microbiology & Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Man. (Trepman); and the University of South Alabama College of Medicine, Mobile, AL (Trepman)

Background: Hemiarthroplasty is a common treatment for displaced femoral neck fractures, but limited Canadian data are available about hemiarthroplasty failure. We evaluated the frequency and predictors of hemiarthroplasty failure in Manitoba.

Methods: In this retrospective multicentre province-wide study, billing and joint registry databases showed 4693 patients who had hemiarthroplasty for treatment of femoral neck fracture in Manitoba over an 11-year period (2005-2015), including 155 hips with subsequent reoperations (open or closed) for treatment of hemiarthroplasty failure. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Pediatric morbidity after oral surgery procedures under general anaesthesia: a systematic review.

Authors:
Ana López Velasco Francisco Javier Carrera Hueso Francisco Javier Silvestre Miguel Puche Torres Pedro Vazquez-Ferreiro

J Stomatol Oral Maxillofac Surg 2022 Aug 9. Epub 2022 Aug 9.

Ophthalmologic Department. Hospital Virxen da Xunqueira, Cee (A Coruña), Spain. Electronic address:

The aim of this study is to carry out a systematic review of the existing literature on postoperative morbidity after general anaesthesia (GA) in the dental care of paediatric patients, its frequency, characteristics and association with the intervention performed.

Material And Methods: An exhaustive search of the literature published up to 23 February 2022 was carried out in PubMed, Web of Science, Cochrane and EBSCO, with the following strategy: (infant OR child OR adolescent) AND (Oral Surgical Procedures OR Dentistry, Operative) AND Anesthesia, General AND Postoperative Complications.

Results: The most frequent reason for the indication of general anaesthesia was dental caries and its complications (up to 91. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Enhanced bedside mortality prediction combining point-of-care lactate and the quick Sequential Organ Failure Assessment (qSOFA) score in patients hospitalised with suspected infection in southeast Asia: a cohort study.

Authors:
Shelton W Wright Viriya Hantrakun Kristina E Rudd Chuen-Yen Lau Khie Chen Lie Nguyen Van Vinh Chau Prapit Teparrukkul T Eoin West Direk Limmathurotsakul

Lancet Glob Health 2022 Sep;10(9):e1281-e1288

Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Background: Simple, bedside prediction of infection-related mortality in low-resource settings is crucial for triage and resource-utilisation decisions. We aimed to evaluate mortality prediction by combining point-of-care venous lactate with the quick Sequential Organ Failure Assessment (qSOFA) score in adult patients admitted to hospital with suspected infection in southeast Asia.

Methods: We performed a cohort study by prospectively enrolling patients aged 18 years or older who had been admitted to hospital within the previous 24 h for suspected infection (with at least three documented systemic manifestations of infection according to the 2012 Surviving Sepsis Campaign) at Sunpasitthiprasong Hospital in Ubon Ratchathani, Thailand (derivation cohort). Read More

View Article and Full-Text PDF
September 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap